Author Correction: Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure

Affiliations

• ¹ Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1152, New York, 10029, USA.
• ² Pharmacologic Sciences Department, Stony Brook University, Stony Brook, NY, USA.
• ³ Metabolic Phenotyping Core, University of Utah, 15N 2030 E, 585, Radiobiology building, Room 151, Salt Lake City, UT, 84112, USA.
• ⁴ Weill Center for Metabolic Health and Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.
• ⁵ Institut Cochin, Université de Paris, INSERM, CNRS, F-75014, Paris, France.
• ⁶ Alpenglow Biosciences, Inc., 98103, Seattle, WA, USA.
• ⁷ 12800 East 19th Ave, Anschutz Medical Campus, Room P18-9403, University of Colorado, Aurora, CO, 80045, USA.
• ⁸ Division of Endocrinology and Metabolism and Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA.
• ⁹ Section of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, One Baylor Plaza, MS: 185, R614, 77030, Houston, TX, USA.
• ¹⁰ Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1152, New York, 10029, USA. donald.scott@mssm.edu.